| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60505-4532-2 | 60505-4532 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20230309 | N/A | ANDA | ANDA211022 | Apotex Corp. | LENALIDOMIDE | 2.5 mg/1 | 28 CAPSULE in 1 BOTTLE (60505-4532-2) |
| 60505-4533-2 | 60505-4533 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20220906 | N/A | ANDA | ANDA211022 | Apotex Corp. | LENALIDOMIDE | 5 mg/1 | 28 CAPSULE in 1 BOTTLE (60505-4533-2) |
| 60505-4534-2 | 60505-4534 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20220906 | N/A | ANDA | ANDA211022 | Apotex Corp. | LENALIDOMIDE | 10 mg/1 | 28 CAPSULE in 1 BOTTLE (60505-4534-2) |
| 60505-4535-2 | 60505-4535 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20220906 | N/A | ANDA | ANDA211022 | Apotex Corp. | LENALIDOMIDE | 15 mg/1 | 21 CAPSULE in 1 BOTTLE (60505-4535-2) |
| 60505-4536-2 | 60505-4536 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20230309 | N/A | ANDA | ANDA211022 | Apotex Corp. | LENALIDOMIDE | 20 mg/1 | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| 60505-4537-2 | 60505-4537 | HUMAN PRESCRIPTION DRUG | Lenalidomide | Lenalidomide | CAPSULE | ORAL | 20220906 | N/A | ANDA | ANDA211022 | Apotex Corp. | LENALIDOMIDE | 25 mg/1 | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |